FIELD: medicine, virology, pharmacy. SUBSTANCE: invention relates to the development of novel medicinal preparations used for treatment and prophylaxis of viral diseases. The preparation has human leukocyte interferon and ointment base including polyethylene oxide with molecular mass 1500 Da and water taken in the following ratio of components, wt.%: human leukocyte interferon with activity 3000 IU/g, 5.0; water, 19.0; and polyethylene oxide-1500 up to 100.0. EFFECT: broadened arsenal of agents for treatment and prophylaxis of viral diseases. 4 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| ANTIVIRAL AGENT | 2001 |
|
RU2204410C1 |
| ANTIVIRAL GEL AS GEL BASED ON HUMAN LEUKOCYTE INTERFERON | 2005 |
|
RU2302881C2 |
| METHOD FOR PROPHYLAXIS OF ACUTE RESPIRATORY-VIRAL INFECTION IN CHILDREN OF EARLY AGE | 2001 |
|
RU2214272C2 |
| ANTIVIRAL PREPARATION FOR EXTERNAL APPLICATION BASED UPON HYALURONIC ACID | 1999 |
|
RU2178693C2 |
| ANTIVIRUS AGENT WITH HUMAN LEUKOCYTIC HUMAN INTERFERON BASED ON CHITOSAN SUCCINATE | 2009 |
|
RU2404796C1 |
| ANTIVIRAL AGENT - NASAL DROPS "GRIPPFERON" | 1999 |
|
RU2140285C1 |
| MEANS FOR NASAL APPLICATION | 2016 |
|
RU2629330C1 |
| ANTIVIRAL AGENT NASAL DROPS | 2000 |
|
RU2162337C1 |
| TOPICAL AND EXTERNAL TILORONE PHARMACEUTICAL COMPOSITION FOR TREATMENT OF PURULENT-DESTRUCTIVE MUCOSAL AND SKIN DISEASES, SYSTEMIC DISEASES IN IMMUNODEFICIENCY STATES | 2008 |
|
RU2401104C2 |
| HYPOALLERGENIC MEDICINAL AGENT APPLIED FOR TREATMENT OF INFECTION-INFLAMMATORY DISEASES OF DIFFERENT AETIOLOGY | 2007 |
|
RU2326688C1 |
